This two‑day virtual event explores how automation, robotics, and AI/ML are reshaping CMC potency assays across the biopharmaceutical lifecycle. As regulators intensify scrutiny on data integrity and assay reproducibility, this conference highlights how automated platforms from simple liquid handlers to fully robotic systems strengthen cost-effective CMC strategy, analytical rigor, and inspection‑ready execution.

Attendees will gain practical insights into automated assay design, qualification, validation, lifecycle management, digital data capture, AI‑enabled analytics, and global regulatory expectations. Special emphasis is placed on how automation reduces variability, enhances data integrity, and supports defensible decision‑making across diverse biopharmaceutical modalities.

Designed for CMC, QA/QC, Analytical Development, Bioassay, Automation Engineering, Regulatory Affairs, and Technical Operations professionals, this event equips teams to build automated potency programs that are fit‑for‑purpose, compliant, scalable, and resilient across the product lifecycle.